Metraipolis › archive › dc_9282c3d64345

Gemcitabine + Cisplatin + S-1 Treatment for Advanced Cholangiocarcinoma: Cost-Effective, with Better Progression-Free Survival Versus Standard Treatment with… — Europe PMC PMID:41463222

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41463222
DOI
10.3390/cancers17243971
License (as archived)
solo-consultazione
Archived
2026-11-07T16:41:49.523Z
SHA-256 of the archived text
7eb6b5c2426f446400433d022e55b78e6c0717a35317858be273ff4365d1dfd7
Stable URL of this page
https://metraipolis.com/documento/dc_9282c3d64345

How to cite

Gemcitabine + Cisplatin + S-1 Treatment for Advanced Cholangiocarcinoma: Cost-Effective, with Better Progression-Free Survival Versus Standard Treatment with… — Europe PMC PMID:41463222 — Europe PMC (en), https://europepmc.org/article/MED/41463222 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9282c3d64345 (Metraipolis archive dc_9282c3d64345, sha256 7eb6b5c2426f446400433d022e55b78e6c0717a35317858be273ff4365d1dfd7)
BibTeX
@misc{dc9282c3d64345,
  title = {Gemcitabine + Cisplatin + S-1 Treatment for Advanced Cholangiocarcinoma: Cost-Effective, with Better Progression-Free Survival Versus Standard Treatment with… — Europe PMC PMID:41463222},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41463222},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9282c3d64345; sha256 7eb6b5c2426f446400433d022e55b78e6c0717a35317858be273ff4365d1dfd7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41463222. Agents can read the archived copy with the MCP tool read_document.